Quinasas disponibles en los servicios de caracterización cinética
|
|
- Roberta Olivia Wright
- 8 years ago
- Views:
Transcription
1 s disponibles en los servicios de caracterización cinética ABL1 ABL1 TK abelson tyrosine kinase ABL1 E255K ABL1 TK abelson tyrosine kinase ABL1 G250E ABL1 TK abelson tyrosine kinase ABL1 Y253F ABL1 TK abelson tyrosine kinase ABL2 ABL2 TK abelson tyrosine kinase 2 ACVR1 ACVR1 TKL activin A receptor, type I ACVR2A ACVR2A TKL activin A receptor, type IIA ACVR2B ACVR2B TKL activin A receptor, type IIB AMPKa1 PRKAA1 CAMK protein kinase, AMP-activated, alpha 1 catalytic subunit AMPKa2 PRKAA2 CAMK protein kinase, AMP-activated, alpha 2 catalytic subunit AURKA AURKA Other aurora kinase A AURKB AURKB Other aurora kinase B AXL AXL TK AXL receptor tyrosine kinase BLK BLK TK B lymphoid tyrosine kinase BMPR1A BMPR1A TKL bone morphogenetic protein receptor, type IA BMX BMX TK BMX non-receptor tyrosine kinase BRAF BRAF TKL v-raf murine sarcoma viral oncogene homolog B1 BRAF V599E BRAF TKL v-raf murine sarcoma viral oncogene homolog B1 BRK PTK6 TK PTK6 protein tyrosine kinase 6 BRSK1 BRSK1 CAMK BR serine/threonine kinase 1 BTK BTK TK Bruton agammaglobulinemia tyrosine kinase CAMK1D CAMK1D CAMK calcium/calmodulin-dependent protein kinase ID CAMK2A CAMK2A CAMK calcium/calmodulin-dependent protein kinase II alpha CAMK2B CAMK2B CAMK calcium/calmodulin-dependent protein kinase II beta CAMK2D CAMK2D CAMK calcium/calmodulin-dependent protein kinase II delta CAMK4 CAMK4 CAMK calcium/calmodulin-dependent protein kinase IV CAMKK1 CAMKK1 Other calcium/calmodulin-dependent protein kinase kinase 1, alpha CAMKK2 CAMKK2 Other calcium/calmodulin-dependent protein kinase kinase 2, beta CDK1/cyclinB CDK1 CMGC cyclin-dependent kinase 1 CDK2/cyclinA CDK2 CMGC cyclin-dependent kinase 2 CDK5/p25 CDK5 CMGC cyclin-dependent kinase 5 CDK7/cyclinH/MNAT1 CDK7 CMGC cyclin-dependent kinase 7 CDK8/cyclinC CDK8 CMGC cyclin-dependent kinase 8 CDK9/cyclinK CDK9 CMGC cyclin-dependent kinase 9 CDK9/cyclinT1 CDK9 CMGC cyclin-dependent kinase 9 CHEK1 CHEK1 CAMK CHK1 checkpoint homolog CHEK2 CHEK2 CAMK CHK2 checkpoint homolog CLK1 CLK1 CMGC CDC-like kinase 1 CLK2 CLK2 CMGC CDC-like kinase 2 CLK4 CLK4 CMGC CDC-like kinase 4 CSF1R CSF1R TK colony stimulating factor 1 receptor CSK CSK TK c-src tyrosine kinase CSNK1D CSNK1D CK1 casein kinase 1, delta CSNK1E CSNK1E CK1 casein kinase 1, epsilon CSNK1G1 CSNK1G1 CK1 casein kinase 1, gamma 1 CSNK1G2 CSNK1G2 CK1 casein kinase 1, gamma 2 CSNK1G3 CSNK1G3 CK1 casein kinase 1, gamma 3 Ensayos de caracterización cinética pág. 1
2 DAPK2 DAPK2 CAMK death-associated protein kinase 2 DDR1 DDR1 TK discoidin domain receptor family, member 1 DDR2 DDR2 TK discoidin domain receptor family, member 2 DMPK DMPK AGC dystrophia myotonica-protein kinase DYRK1A DYRK1A CMGC dual-specificity tyrosine-(y)-phosphorylation regulated kinase 1A DYRK1B DYRK1B CMGC dual-specificity tyrosine-(y)-phosphorylation regulated kinase 1B DYRK3 DYRK3 CMGC dual-specificity tyrosine-(y)-phosphorylation regulated kinase 3 EGFR EGFR TK epidermal growth factor receptor EGFR L858R EGFR TK epidermal growth factor receptor EGFR L861Q EGFR TK epidermal growth factor receptor EGFR T790M EGFR TK epidermal growth factor receptor EGFR T790M L858R EGFR TK epidermal growth factor receptor EIF2AK2 EIF2AK2 Other eukaryotic translation initiation factor 2-alpha kinase 2 EPHA1 EPHA1 TK EPH receptor A1 EPHA2 EPHA2 TK EPH receptor A2 EPHA3 EPHA3 TK EPH receptor A3 EPHA4 EPHA4 TK EPH receptor A4 EPHA5 EPHA5 TK EPH receptor A5 EPHA7 EPHA7 TK EPH receptor A7 EPHA8 EPHA8 TK EPH receptor A8 EPHB1 EPHB1 TK EPH receptor B1 EPHB2 EPHB2 TK EPH receptor B2 EPHB3 EPHB3 TK EPH receptor B3 EPHB4 EPHB4 TK EPH receptor B4 ERBB4 ERBB4 TK v-erb-a erythroblastic leukemia viral oncogene homolog 4 FAK PTK2 TK PTK2 protein tyrosine kinase 2 FAK2 PTK2B TK protein tyrosine kinase 2 beta FER FER TK fer (fps/fes related) tyrosine kinase FES FES TK feline sarcoma oncogene FGFR1 FGFR1 TK fibroblast growth factor receptor 1 FGFR2 FGFR2 TK fibroblast growth factor receptor 2 FGFR3 FGFR3 TK fibroblast growth factor receptor 3 FGFR3 K650E FGFR3 TK fibroblast growth factor receptor 3 FGR FGR TK Gardner-Rasheed feline sarcoma viral oncogene homolog FLT1 FLT1 TK fms-related tyrosine kinase 1 FLT3 FLT3 TK fms-related tyrosine kinase 3 FLT3 D835Y FLT3 TK fms-related tyrosine kinase 3 FLT4 FLT4 TK fms-related tyrosine kinase 4 FRK FRK TK fyn-related kinase FYN FYN TK FYN oncogene related to SRC, FGR, YES GRK4 GRK4 AGC G protein-coupled receptor kinase 4 GRK5 GRK5 AGC G protein-coupled receptor kinase 5 GRK6 GRK6 AGC G protein-coupled receptor kinase 6 GRK7 GRK7 AGC G protein-coupled receptor kinase 7 GSK3A GSK3A CMGC glycogen synthase kinase 3 alpha GSK3B GSK3B CMGC glycogen synthase kinase 3 beta HCK HCK TK hemopoietic cell kinase HIPK3 HIPK3 CMGC homeodomain interacting protein kinase 3 IGF1R IGF1R TK insulin-like growth factor 1 receptor IKKa CHUCK Other inhibitor of nuclear factor kappa-b kinase subunit alpha IKKb IKBKB Other inhibitor of nuclear factor kappa-b kinase subunit beta Ensayos de caracterización cinética pág. 2
3 IKKe IKBKE Other inhibitor of nuclear factor kappa-b kinase subunit epsilon INSR INSR TK insulin receptor IRAK1 IRAK1 TKL interleukin-1 receptor-associated kinase 1 IRAK4 IRAK4 TKL interleukin-1 receptor-associated kinase 4 ITK ITK TK IL2-inducible T-cell kinase JAK2 JAK2 TK Janus kinase 2 JAK2, JH1 JH2 JAK3 TK Janus kinase 2 JAK3 JAK3 TK Janus kinase 3 JNK1 MAPK8 CMGC mitogen-activated protein kinase 8 JNK2 MAPK9 CMGC mitogen-activated protein kinase 9 JNK2, inactive MAPK9 CMGC mitogen-activated protein kinase 9 JNK3 MAPK10 CMGC mitogen-activated protein kinase 10 KDR KDR TK kinase insert domain receptor KIT KIT TK kit oncogene KIT T670I KIT TK kit oncogene KIT V654A KIT TK kit oncogene LCK LCK TK lymphocyte-specific protein tyrosine kinase LIMK1 LIMK1 TKL LIM domain kinase 1 LIMK2 LIMK2 TKL LIM domain kinase 2 LRRK2 LRRK2 TKL leucine-rich repeat kinase 2 LRRK2 G2019S LRRK2 TKL leucine-rich repeat kinase 2 LRRK2 I2020T LRRK2 TKL leucine-rich repeat kinase 2 LRRK2 R1441C LRRK2 TKL leucine-rich repeat kinase 2 LTK LTK TK leukocyte tyrosine kinase LYN LYN TK v-yes-1 Yamaguchi sarcoma viral related oncogene homolog MAP2K1 S218D S222D MAP2K1 STE mitogen-activated protein kinase kinase 1 MAP3K2 MAP3K2 STE mitogen-activated protein kinase kinase kinase 2 MAP3K3 MAP3K3 STE mitogen-activated protein kinase kinase kinase 3 MAP3K5 MAP3K5 STE mitogen-activated protein kinase kinase kinase 5 MAP3K7/MAP3K7IP1 MAP3K7 STE mitogen-activated protein kinase kinase kinase 7 MAP4K2 MAP4K2 STE mitogen-activated protein kinase kinase kinase kinase 2 MAP4K4 MAP4K4 STE mitogen-activated protein kinase kinase kinase kinase 4 MAP4K5 MAP4K5 STE mitogen-activated protein kinase kinase kinase kinase 5 MAPKAPK5 MAPKAPK5 CAMK mitogen-activated protein kinase-activated protein kinase 5 MARK1 MARK1 CAMK MAP/microtubule affinity-regulating kinase 1 MARK2 MARK2 CAMK MAP/microtubule affinity-regulating kinase 2 MARK4 MARK4 CAMK MAP/microtubule affinity-regulating kinase 4 MEK1 MAP2K1 STE mitogen-activated protein kinase kinase 1 MEK1, inactive MAP2K1 STE mitogen-activated protein kinase kinase 1 MEK1 S218D S222D MAP2K1 STE mitogen-activated protein kinase kinase 2 MEK2 MAP2K2 STE mitogen-activated protein kinase kinase 2 MEK3 MAP2K3 STE mitogen-activated protein kinase kinase 3 MEK6 MAP2K6 STE mitogen-activated protein kinase kinase 6 MEK6 S207E T211E MAP2K6 STE mitogen-activated protein kinase kinase 6 MELK MELK CAMK maternal embryonic leucine zipper kinase MER MERTK TK c-mer proto-oncogene tyrosine kinase MET MET TK met proto-oncogene (hepatocyte growth factor receptor) MET M1250T MET TK met proto-oncogene (hepatocyte growth factor receptor) MINK1 MINK1 STE misshapen-like kinase 1 MKNK2 MKNK2 CAMK MAP kinase interacting serine/threonine kinase 2 MLK1 MAP3K9 TKL mitogen-activated protein kinase kinase kinase 9 Ensayos de caracterización cinética pág. 3
4 MLK2 MAP3K10 TKL mitogen-activated protein kinase kinase kinase 10 MLK3 MAP3K11 TKL mitogen-activated protein kinase kinase kinase 11 MRCKA CDC42BPA AGC CDC42 binding protein kinase alpha (DMPK-like) MRCKA CDC42BPB AGC CDC42 binding protein kinase beta (DMPK-like) MST1R MST1R TK macrophage stimulating 1 receptor mtor FRAP Atypical FK506 binding protein 12-rapamycin associated protein 1 MUSK MUSK TK muscle, skeletal, receptor tyrosine kinase MYLK MYLK CAMK myosin, light chain kinase MYLK2 MYLK2 CAMK myosin light chain kinase 2, skeletal muscle NEK2 NEK2 Other NIMA (never in mitosis gene a)-related kinase 2 NIK MAP3K14 STE mitogen-activated protein kinase kinase kinase 14 NLK NLK CMGC nemo-like kinase NUAK1 NUAK1 CAMK NUAK family, SNF1-like kinase, 1 p38a MAPK14 CMGC mitogen-activated protein kinase 14 p38a, inactive MAPK14 CMGC mitogen-activated protein kinase 14 p38d, inactive MAPK13 CMGC mitogen-activated protein kinase 13 p38g, inactive MAPK12 CMGC mitogen-activated protein kinase 12 PAK4 PAK4 STE p21(cdkn1a)-activated kinase 4 PAK6 PAK6 STE p21(cdkn1a)-activated kinase 6 PAK7 PAK7 STE p21 protein (Cdc42/Rac)-activated kinase 7 PDGFRA PDGFRA TK platelet-derived growth factor receptor, alpha polypeptide PDGFRA D842V PDGFRA TK platelet-derived growth factor receptor, alpha polypeptide PDGFRA T674I PDGFRA TK platelet-derived growth factor receptor, alpha polypeptide PDGFRA V561D PDGFRA TK platelet-derived growth factor receptor, alpha polypeptide PDGFRB PDGFRB TK platelet-derived growth factor receptor, beta polypeptide PDK1 PDK1 AGC 3-phosphoinositide dependent protein kinase-1 PHKG1 PHKG1 CAMK phosphorylase kinase, gamma 1 PHKG2 PHKG2 CAMK phosphorylase kinase, gamma 2 PIK3CA/PIK3R1 PIK3CA Lipid phosphatidylinositol-4,5-bisphosphate 3-kinase alpha PIK3CD/PIK3R1 PIK3CA Lipid phosphatidylinositol-4,5-bisphosphate 3-kinase delta PIK3CG PIK3CG Lipid phosphatidylinositol-4,5-bisphosphate 3-kinase gamma PIM1 PIM1 CAMK pim-1 oncogene PIM2 PIM2 CAMK pim-2 oncogene PKACa PRKACA AGC protein kinase, camp-dependent, catalytic, alpha PKCh PRKCH AGC protein kinase C, eta PKCi PRKCI AGC protein kinase C, iota PKCt PRKCQ AGC protein kinase C, theta PKD1 PRKD1 CAMK protein kinase D1 PKD2 PRKD2 CAMK protein kinase D2 PKD3 PRKD3 CAMK protein kinase D3 PKG1 PRKG1 AGC protein kinase, cgmp-dependent, type I PKG2 PRKG2 AGC protein kinase, cgmp-dependent, type II PKN1 PKN1 AGC protein kinase N1 PRKX PRKX AGC protein kinase, X-linked RAF1 Y340D Y341D RAF1 TKL v-raf-1 murine leukemia viral oncogene homolog 1 RET RET TK ret proto-oncogene RET V804L RET TK ret proto-oncogene RET Y791F RET TK ret proto-oncogene RIPK2 RIPK2 TKL receptor-interacting serine-threonine kinase 2 ROCK1 ROCK1 AGC Rho-associated, coiled-coil containing protein kinase 1 ROCK2 ROCK2 AGC Rho-associated, coiled-coil containing protein kinase 2 Ensayos de caracterización cinética pág. 4
5 ROS1 ROS1 TK v-ros UR2 sarcoma virus oncogene homolog 1 RPS6KA1 RPS6KA1 AGC ribosomal protein S6 kinase, 90kDa, polypeptide 1 RPS6KA2 RPS6KA2 AGC ribosomal protein S6 kinase, 90kDa, polypeptide 2 RPS6KA3 RPS6KA3 AGC ribosomal protein S6 kinase, 90kDa, polypeptide 3 RPS6KA3, inactive RPS6KA3 AGC ribosomal protein S6 kinase, 90kDa, polypeptide 3 RPS6KA4 RPS6KA4 AGC ribosomal protein S6 kinase, 90kDa, polypeptide 4 RPS6KA5 RPS6KA5 AGC ribosomal protein S6 kinase, 90kDa, polypeptide 5 RPS6KA6 RPS6KA6 AGC ribosomal protein S6 kinase, 90kDa, polypeptide 6 RPS6KB1 RPS6KB1 AGC ribosomal protein S6 kinase, 70kDa, polypeptide 1 SGK SGK AGC serum/glucocorticoid regulated kinase SGK3 SGK3 AGC serum/glucocorticoid regulated kinase family, member 3 SLK SLK STE STE20-like kinase SNF1LK2 SNF1LK2 CAMK SNF1-like kinase 2 SRC SRC TK v-src sarcoma viral oncogene homolog SRPK2 SRPK2 CMGC SFRS protein kinase 2 STK3 STK3 STE serine/threonine kinase 3 STK4 STK4 STE serine/threonine kinase 4 STK16 STK16 Other serine/threonine kinase 16 STK17A STK17A CAMK serine/threonine kinase 17a STK22D STK22D CAMK testis-specific serine kinase 1B STK25 STK25 STE serine/threonine kinase 25 STK33 STK33 CAMK serine/threonine kinase 33 SYK SYK TK spleen tyrosine kinase TAOK2 TAOK2 STE TAO kinase 2 TAOK3 TAOK3 STE TAO kinase 3 TBK1 TBK1 Other TANK-binding kinase 1 TEC TEC TK tec protein tyrosine kinase TEK TEK TK TEK tyrosine kinase, endothelial TGFBR1 TGFBR1 TKL transforming growth factor, beta receptor I TGFBR2 TGFBR2 TKL transforming growth factor, beta receptor II TNK2 TNK2 TK tyrosine kinase, non-receptor, 2 TTK TTK Other TTK protein kinase TYK2 TYK2 TK tyrosine kinase 2 TYRO3 TYRO3 TK TYRO3 protein tyrosine kinase WNK2 WNK2 Other WNK lysine deficient protein kinase 2 WNK3 WNK3 Other WNK lysine deficient protein kinase 3 YES1 YES1 TK v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 ZAP70 ZAP70 TK zeta-chain (TCR) associated protein kinase 70kDa Ensayos de caracterización cinética pág. 5
6 Conoce a fondo nuestros servicios de caracterización cinética visitando o contáctanos en info@enzymlogic.com Ensayos de caracterización cinética pág. 6
2005 2006 PRODUCT CATALOG. TrueClone: Authentic Full-Length cdna Clones
2005 2006 PRODUCT CATALOG TrueClone: Authentic Full-Length cdna Clones Dear Valued Customer, The completion of the sequencing of the human genome provides us with an enormous amount of data related to
KinoScope Kinase Inhibitor Charts, Product Flyer
Kinocope Kinase nhibitor Charts, Product lyer nterest in any of the products, request or order them at Bio-Connect. Bio-Connect B.V. T L +31 (0)6 36 44 50 T BE +3 (0) 503 03 48 Begonialaan 3a L +31 (0)6
Supporting Information. Copyright Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, 2007
Supporting Information Copyright Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, 2007 Copyright Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim, 2007 Supporting Information for A Multiplexed Protein
targeted therapy a guide for the patient
targeted therapy FOR LUNG CANCER a guide for the patient TABLE OF CONTENTS lung cancer basics... 2-3 Gene changes... 4-5 Testing... 7-8 Targeted therapy... 9-11 Drugs Targeting EGFR... 12 Drugs Targeting
Public-Private Partnerships in early phase clinical research: Spurring access to innovative therapeutics
EPAAC WP8 Research Forum - 2 July, Sofitel Hotel Europe, Brussels Public-Private Partnerships in early phase clinical research: Spurring access to innovative therapeutics JY Blay, Past President EORTC
(accession numbers listed in Table S1), and were to the human genome assembly
Materials and Methods Primer design The cdna sequences of receptor tyrosine kinases were obtained from GenBank (accession numbers listed in Table S1), and were to the human genome assembly (http://genome.ucsc.edu)
B Cell Generation, Activation & Differentiation. B cell maturation
B Cell Generation, Activation & Differentiation Naïve B cells- have not encountered Ag. Have IgM and IgD on cell surface : have same binding VDJ regions but different constant region leaves bone marrow
CancerTREATMENT NGS+ NSCLC Summary Report Page 1 of 7 PATIENT SPECIMEN PHYSICIAN
Page 1 of 7 POSITIVE TEST RESULTS Biomarker Result DETECTED NEGATIVE TEST RESULTS FDA Approved Therapies Targeting Molecular Pathway TEST DESCRIPTION: CancerTREATMENT NGS+ uses Next Generation Sequencing
3) There are different types of extracellular signaling molecules. 4) most signaling molecules are secreted by exocytosis
XIV) Signaling. A) The need for Signaling in multicellular organisms B) yeast need to signal to respond to various factors C) Extracellular signaling molecules bind to receptors 1) most bind to receptors
Understanding series. new. directions. 1-800-298-2436 LungCancerAlliance.org. A guide for the patient
Understanding series LUNG CANCER: new treatment directions 1-800-298-2436 LungCancerAlliance.org A guide for the patient TABLE OF CONTENTS What s New in lung cancer? Advancements...4 Changes in genes that
FAK phospho S732 Antibody, Rabbit Polyclonal Antibody
GenWay Biotech, Inc. 6777 Nancy Ridge Drive San Diego, CA 92121 Tel: (858)458-0866 Fax: (858)458-0833 sales@genwaybio.com FAK phospho S732 Antibody, Rabbit Polyclonal Antibody Catalog Number: 18-272-197354
Dissertation. zur Erlangung des Grades. des Doktors der Naturwissenschaften. der Naturwissenschaftlich-Technischen Fakultät III
Development of new Lead-Like Dual Inhibitors of the cdc2-like Kinase 1 (Clk1) and Dual Specificity Y-phosphorylation Regulated Kinases 1A and 1B (Dyrk1A and Dyrk1B) Dissertation zur Erlangung des Grades
Successes and Limitations of Targeted Cancer Therapy in Lung Cancer
Successes and Limitations of Targeted Cancer Therapy in Lung Cancer Kenichi Suda a, b Tetsuya Mitsudomi a a Division of Thoracic Surgery, Department of Surgery, Kinki University Faculty of Medicine, Osaka-Sayama,
Chapter-21b: Hormones and Receptors
1 hapter-21b: Hormones and Receptors Hormone classes Hormones are classified according to the distance over which they act. 1. Autocrine hormones --- act on the same cell that released them. Interleukin-2
# Circuits relevant to cancer, related to known TFs.
# Circuits relevant to cancer, related to known TFs. # Final dataset of circuits where at least one gene has been annotated as relevant to cancer. # Circuits correspond to blocks separated by a symbol.
Médecine de précision médecine personnalisée en Oncologie. Fabien Calvo, Directeur Recherche et Innovation, INCa, Directeur ITMO Cancer, AVIESAN
Médecine de précision médecine personnalisée en Oncologie Fabien Calvo, Directeur Recherche et Innovation, INCa, Directeur ITMO Cancer, AVIESAN Successful targeted drug development Rapid identification
TEMA 10. REACCIONES INMUNITARIAS MEDIADAS POR CÉLULAS.
TEMA 10. REACCIONES INMUNITARIAS MEDIADAS POR CÉLULAS. The nomenclature of cytokines partly reflects their first-described function and also the order of their discovery. There is no single unified nomenclature,
Validated Cell-Based Assays for Rapid Screening and Functional Characterization of Therapeutic Monoclonal Antibodies
Validated Cell-Based Assays for Rapid Screening and Functional Characterization of Therapeutic Monoclonal Antibodies Abhishek Saharia, Ph. D. Senior Product Manager Validation Assays Drug Discovery Evolution
KOD ÜRÜN AMBALAJ MARKA MAROSEL TIBBİ ÜRÜNLER (0216) 641 01 82
MAROSEL TIBBİ ÜRÜNLER (0216) 641 01 82 CSB-EL018503MO protein phosphatase 1, catalytic subunit, alpha isoform (PPP1CA) ELISA kit 96 tests CUSABİO CSB-EL018503RB protein phosphatase 1, catalytic subunit,
2015 Compound Libraries
21 Compound Libraries Compound Libraries (96-Well) Contents What is a Compound Library? Compound Libraries are ready-to-use chemical libraries used for drug discovery, lab drug screening, drug target identification,
T Cell Maturation,Activation and Differentiation
T Cell Maturation,Activation and Differentiation Positive Selection- In thymus, permits survival of only those T cells whose TCRs recognize self- MHC molecules (self-mhc restriction) Negative Selection-
Copyright 2000-2003 Mark Brandt, Ph.D. 93
Signal transduction In order to interact properly with their environment, cells need to allow information as well as molecules to cross their cell membranes. Information in many single-celled and all multicellular
Unparalleled Product Quality, Validation and Technical Support. Antibodies, Kinases and Kits for. Drug discovery
Unparalleled Product Quality, Validation and Technical Support Antibodies, Kinases and Kits for Drug discovery INNOVATIVE DISCOVERY TOOLS FOR SIGNAL TRANSDUCTION RESEARCH Cell Signaling Technology s Drug
UNMET MEDICAL NEEDS IN NON-SMALL-CELL LUNG CANCER TREATMENT: HOW TO DESIGN PRE-EMPTIVE COMBINATION THERAPIES
UNMET MEDICAL NEEDS IN NON-SMALL-CELL LUNG CANCER TREATMENT: HOW TO DESIGN PRE-EMPTIVE COMBINATION THERAPIES *Niki Karachaliou, 1 Rafael Rosell 1,2,3 1. Translational Research Unit, Dr Rosell Oncology
Protein Kinase Inhibitors for the Treatment of Disease: The Promise and the Problems
HEP (2005) 167:1 7 Springer-Verlag 2005 Protein Kinase Inhibitors for the Treatment of Disease: The Promise and the Problems P. Cohen Medical Research Council Protein Phosphorylation Unit, University of
TEST AND PRICE LIST FOR NEXT GENERATION SEQUENCING
AIP ALK APC Mutation Detection Techniques Ai Saple Type TAT ATM BAP1 BLM BMPR1A BRCA1 BRCA2 BRIP1 BUB1B CDC73 CDH1 CDK4 CDKN1C CDKN2A CEBPA CEP57 CHEK2 CYLD DDB2 DICER1 DIS3L2 EGFR EPCAM ERCC2 ERCC3 ERCC4
Non-Small Cell Lung Cancer
Non-Small Cell Lung Cancer in East tasia Chia-Chi (Josh) Lin, MD, PhD 林 家 齊 Director of Phase I Center, e Department of Oncology, National Taiwan University Hospital Clinical Associate Professor, Department
The Advantages and Disadvantages of Using Gene Ontology
Extracting Biological Information from Gene Lists Simon Andrews, Laura Biggins, Boo Virk simon.andrews@babraham.ac.uk laura.biggins@babraham.ac.uk boo.virk@babraham.ac.uk v1.0 Biological material Sample
Control of Gene Expression
Control of Gene Expression What is Gene Expression? Gene expression is the process by which informa9on from a gene is used in the synthesis of a func9onal gene product. What is Gene Expression? Figure
Amplification Products for PCR and RT-PCR
Panel A : Green dye D.36 Panel B : Regular PCR Human IL-18 gene derived fron Spleen cdna was analyzed by two-step RT-PCR using PCR Primer of T63710 (Lane 1-7 : 5 fold series dilution, cdna from 100 ng
Protein engineering for structural biology
Protein engineering for structural biology J. Michael Sauder, Ph.D. Lilly Biotechnology Center Eli Lilly and Company San Diego, CA 92121 michael.sauder@lilly.com PSDI 2012, Nov 12-13 Structural Biology
Corporate Medical Policy
Corporate Medical Policy Molecular Analysis for Targeted Therapy for Non-Small Cell Lung File Name: Origination: Last CAP Review: Next CAP Review: Last Review: molecular_analysis_for_targeted_therapy_for_non_small_cell_lung_cancer
α α λ α = = λ λ α ψ = = α α α λ λ ψ α = + β = > θ θ β > β β θ θ θ β θ β γ θ β = γ θ > β > γ θ β γ = θ β = θ β = θ β = β θ = β β θ = = = β β θ = + α α α α α = = λ λ λ λ λ λ λ = λ λ α α α α λ ψ + α =
The immune system. Bone marrow. Thymus. Spleen. Bone marrow. NK cell. B-cell. T-cell. Basophil Neutrophil. Eosinophil. Myeloid progenitor
The immune system Basophil Neutrophil Bone marrow Eosinophil Myeloid progenitor Dendritic cell Pluripotent Stem cell Lymphoid progenitor Platelets Bone marrow Thymus NK cell T-cell B-cell Spleen Cancer
MAKROSEL TIBBİ ÜRÜNLER - 0(216) 641 01 82
MAKROSEL TIBBİ ÜRÜNLER - 0(216) 641 01 82 CSB-EL009008BO frizzled-related protein (FRZB) ELISA kit 96 tests CUSABİO CSB-EL009008CH frizzled-related protein (FRZB) ELISA kit 96 tests CUSABİO CSB-EL009008HU
Mechanism of hormone action
Mechanism of hormone action ผศ.ดร.พญ.ส ว ฒณ ค ปต ว ฒ ภาคว ชาสร รว ทยา คณะแพทยศาสตร ศ ร ราชพยาบาล Aims What is hormone receptor Type of hormone receptors - cell surface receptor - intracellular receptor
Akt (Phospho-Ser473) Antibody, Rabbit Polyclonal Antibody
GenWay Biotech, Inc. 6777 Nancy Ridge Drive San Diego, CA 92121 Tel: (858)458-0866 Fax: (858)458-0833 sales@genwaybio.com Akt (Phospho-Ser473) Antibody, Rabbit Polyclonal Antibody Catalog Number: 18-785-210009
Lung Cancer Research: From Prevention to Cure!
Lung Cancer Research: From Prevention to Cure! Ravi Salgia, M.D, Ph.D Associate Professor of Medicine Director, Thoracic Oncology Research Program Department of Medicine Section of Hematology/Oncology
5 CELL SIGNALING. Introduction A. Types of Signaling B. Types of Receptors C. Other Conserved Functions
Signaling 1 5 CELL SIGNALING I II Introduction A. Types of Signaling B. Types of Receptors C. Other Conserved Functions G Protein-coupled Receptors A. Heterotrimeric G proteins B. G-protein coupled receptors
Control of Gene Expression
Control of Gene Expression (Learning Objectives) Explain the role of gene expression is differentiation of function of cells which leads to the emergence of different tissues, organs, and organ systems
Pharmacogenomics of EGFR-targeted therapies in non small cell lung cancer: EGFR and beyond
Delaney et al. Chinese Journal of Cancer (2015) 34:7 DOI 10.1186/s40880-015-0007-9 REVIEW Open Access Pharmacogenomics of EGFR-targeted therapies in non small cell lung cancer: EGFR and beyond Christopher
NEW BIOACTIVE PRODUCTS. B-RAF Inhibitors
B-RAF Inhibitors BAM66400 CHF 5074, 96+% 1mg: $300 A novel, potent and selective small molecule B-Raf kinase BAM66393 GDC-0879, BAM66396 PLX-4032 (RG7204/Vemurafenib/Zelboraf), 96+% BAM66397 PLX-4720,
THE CELL. A Molecular Approach. Sixth Edition. Boston University
THE CELL A Molecular Approach Sixth Edition Geoffrey M. Cooper Robert E. Hausman Boston University Sinauer Associates, Inc. Publishers Sunderland, Massachusetts U.S.A. Brief Contents PART I Introduction
PRODUCT CODE PRODUCTS NAME QUANTITIY MANUFACTURE EIA4088 IA-2 Ab (min. order 11 kits) DRG RIAE/96R IA-2 Autoantibody 96 tests BIOVENDOR EIA1593 IAA
PRODUCT CODE PRODUCTS NAME QUANTITIY MANUFACTURE EIA4088 IA-2 Ab (min. order 11 kits) DRG RIAE/96R IA-2 Autoantibody 96 tests BIOVENDOR EIA1593 IAA (Insulin Autoantibody) DRG EIA1594 ICA (Intra-Cell Autoantibody)
O ρόλος της ακετυλοχολίνης στη σύσπαση και τον πολλαπλασιασµό των ΛΜΚ (του αναπνευστικού) Απ. Χατζηευθυµίου 2015
O ρόλος της ακετυλοχολίνης στη σύσπαση και τον πολλαπλασιασµό των ΛΜΚ (του αναπνευστικού) Απ. Χατζηευθυµίου 2015 Σύσπαση ΛΜΙ An increase in free intracellular calcium can result from either increased flux
A disease of populations of cells that live, divide, invade and spread without regard to normal limits
1 Targeted Cancer Therapies Mark McKeage Medical Oncology Specialist Professor in Clinical Pharmacology 2 Cancer Definition- A disease of populations of cells that live, divide, invade and spread without
MEDICAL POLICY EFFECTIVE DATE: 12/20/07 REVISED DATE: 12/18/08, 12/17/09, 02/17/11, 12/15/11, 12/20/12, 12/19/13, 02/19/15
MEDICAL POLICY SUBJECT: GENOTYPING - EPIDERMAL GROWTH PAGE: 1 OF: 6 If a product excludes coverage for a service, it is not covered, and medical policy criteria do not apply. If a commercial product, including
plaque reduction assay, modified dye uptake assay including formazan test, dye uptake assay
Sauerbrei A, Bohn-Wippert K, Kaspar M, Krumbholz A, Karrasch M, Zell R. 2015. Database on natural polymorphisms and resistance-related non-synonymous mutations in thymidine kinase and DNA polymerase genes
Lung Cancer Genomics and Patient Individualization
Lung Cancer Genomics and Patient Individualization Ming Sound Tsao, MD, FRCPC Qasim Choksi Chair in Lung Cancer Translational Research University Health Network OCI/PMH Leading Causes of Deaths (WHO) In
Clinical Challenges to Current Molecularly Targeted Therapies in Lung Cancer
imedpub Journals http://www.imedpub.com Archives Archives in Cancer in Cancer Research Research ISSN 2254-6081 Abstract Clinical Challenges to Current Molecularly Targeted Therapies in Lung Cancer Lung
Nuovi Scenari in Oncologia. G. Zoppoli X-Files in Nutrizione Clinica e Artificiale, 08/06/2012
Nuovi Scenari in Oncologia G. Zoppoli X-Files in Nutrizione Clinica e Artificiale, 08/06/2012 WHAT is cancer? «Cancer is a genetic disease of the somatic cell» [B. Vogelstein] Ten years ago Now [Cell.
La diagnostica molecolare nelle neoplasie colo-rettali. A do Scarpa. U iversita di Vero a
La diagnostica molecolare nelle neoplasie colo-rettali C-NET A do Scarpa e Dipartime to Pato ogia e U iversita di Vero a La stessa malattia puo avere diverse patogenesi cucchiaio moneta forchetta Gastrointestinal
HitHunter Assay Kits
Part of GE Healthcare HitHunter Assay Kits If you need: Homogeneity Simplicity Proven technology Versatility Choice of readout HitHunter kits offer: No mixing steps and a limited number of reagent additions.
Ph.D. thesis by Kurt Højlund. The Diabetes Research Centre Department of Medical Endocrinology Odense University Hospital
$ Skeletal Muscle Insulin Resistance in Type 2 Diabetes Investigated by Two Approaches: Studies of Insulin Signaling into Glycogen Synthase and Proteome Analysis Ph.D. thesis by Kurt Højlund The Diabetes
Oncogenes and Cancer B-1
Oncogenes and Cancer B-1 Figure 30.1 The frequency of newly diagnosed cancers increases sharply with age. Each point on the graph gives the incidence over a one year period for the preceding age group
Signaling by Distinct Classes of Phosphoinositide 3-Kinases
Experimental Cell Research 253, 239 254 (1999) Article ID excr.1999.4701, available online at http://www.idealibrary.com on Signaling by Distinct Classes of Phosphoinositide 3-Kinases B. Vanhaesebroeck*,1
Signal:noise? The importance of the preanalytical phase in sample storage. Scott D. Patterson, PhD Executive Director, Medical Sciences
Signal:noise? The importance of the preanalytical phase in sample storage Scott D. Patterson, PhD Executive Director, Medical Sciences Outline Biomarkers in early drug development Biobank considerations
Mass Spectrometry of Cancer Tumors - A Review
Identification of kinase inhibitor targets in the lung cancer microenvironment by chemical and phosphoproteomics Manuela Gridling 1, Scott B. Ficarro 3-5, Florian P. Breitwieser 1, Lanxi Song 6, Katja
Classify chromosomes in a karyotype according to size and centromere position. Identify metacentric, submetacentric and acrocentric chromosomes
Mitosis, Meiosis and the Cell Cycle Prof. Alfred Cuschieri University of Malta Department of Anatomy Objectives By the end of the session the student shoud be able to: Define the meaning of chromosomes
Insulin resistance: a phosphorylation-based uncoupling of insulin signaling
437 Research News Insulin resistance: a phosphorylation-based uncoupling of insulin signaling Yehiel Zick Insulin resistance refers to a decreased capacity of circulating insulin to regulate nutrient metabolism.
elevata sensibilità possibilità di customizzazioni
Abcam Abnova Amresco Bender MedSystems Biobasic Bioo Scientific CellnTec Chemisafe Chemicon Millipore Covance ebioscience ECMBiosciences Kogene Koma Biotech KPL Genetex GoodFellow ICLlabs Oxis - Percipio
Transconductance Amplifier for ERK pathway of EGF/ Insulin leading to Cell Survival/ Death. J Pharm Biomed Sci. 2014;04(08):705-711.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL SCIENCES Jain S., Implementation of Fuzzy System using Operational Transconductance Amplifier for ERK pathway of EGF/ Insulin leading to Cell Survival/ Death. J
Using TaqMan Endogenous Control Assays to select an endogenous control for experimental studies
APPLICATION NOTE TaqMan Gene Expression Assays Using TaqMan Endogenous Control Assays to select an endogenous control for experimental studies Introduction Quantitative real-time PCR (qpcr) allows for
The Biochemistry of Cancer Additional readings; pp. 682 (oncogenes); pp. 680 (Ras) ; and 916 (P53 and apoptosis)
The Biochemistry of Cancer Additional readings; pp. 682 (oncogenes); pp. 680 (Ras) ; and 916 (P53 and apoptosis) Introduction: Cancer cells are characterized by three distinguishing properties: 1) a diminished
Novel Global Network Scores to Analyze Kinase Inhibitor Profiles
The Fourth International Conference on Computational Systems Biology (ISB2010) Suzhou, China, September 9 11, 2010 Copyright 2010 ORSC & APORC, pp. 305 313 Novel Global Network Scores to Analyze Kinase
MILLIPLEX MAP and Cell Signaling Pathways
Data Sheet Product Selection Guide MILLIPLE MAP and Cell Signaling Pathways Your Source for Luminex xmap Technology Growth IGF-R Ins-R PDGF-Rα PDGF-Rβ EGF-R c-met c-kit Cytokines CD3ε TCR CD3ζ slg CD79α
Oncomine Cancer Panel Patient Test Report
Oncomine Cancer Panel Patient Test Report SUBJECT NFORMATON Pre-Screening Subject No.: Life Technologies Clinical Services Lab 910 Riverside Parkway, Suite 60 West Sacramento, CA 95605 Ph: (888) 734-8588
Copyright 2000-2003 Mark Brandt, Ph.D. 54
Pyruvate Oxidation Overview of pyruvate metabolism Pyruvate can be produced in a variety of ways. It is an end product of glycolysis, and can be derived from lactate taken up from the environment (or,
High-Throughput Sequence Analysis of Turbot (Scophthalmus maximus) Transcriptome Using 454- Pyrosequencing for the Discovery of Antiviral Immune Genes
High-Throughput Sequence Analysis of Turbot (Scophthalmus maximus) Transcriptome Using 454- Pyrosequencing for the Discovery of Antiviral Immune Genes Patricia Pereiro 1, Pablo Balseiro 1, Alejandro Romero
Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia
RESEARCH ARTICLE Individualized Systems Medicine Strategy to Tailor Treatments for Patients with Chemorefractory Acute Myeloid Leukemia Tea Pemovska1, Mika Kontro2, Bhagwan Yadav1, Henrik Edgren1, Samuli
Regulation of enzyme activity
1 Regulation of enzyme activity Regulation of enzyme activity is important to coordinate the different metabolic processes. It is also important for homeostasis i.e. to maintain the internal environment
Multiple Choice Write the letter that best answers the question or completes the statement on the line provided.
Name lass Date hapter 12 DN and RN hapter Test Multiple hoice Write the letter that best answers the question or completes the statement on the line provided. Pearson Education, Inc. ll rights reserved.
Describe how these hormones exert control quickly by changes in phosphorylation state of enzyme, and more slowly by changes of gene expression
Section VIII. Section VIII. Tissue metabolism Many tissues carry out specialized functions: Ch. 43 look at different hormones affect metabolism of fuels, especially counter-insulin Ch. 44 Proteins and
Focal point: Biochemistry of stem cells
Focal point: Biochemistry of stem cells Stem cells have become a major impact penetrating nearly all disciplines of live sciences dealing with eukaryotic cells or organisms. We predict that in the near
RNA and Protein Synthesis
Name lass Date RN and Protein Synthesis Information and Heredity Q: How does information fl ow from DN to RN to direct the synthesis of proteins? 13.1 What is RN? WHT I KNOW SMPLE NSWER: RN is a nucleic
What is New in Oncology. Michael J Messino, MD Cancer Care of WNC An affiliate of Mission hospitals
What is New in Oncology Michael J Messino, MD Cancer Care of WNC An affiliate of Mission hospitals Personalized Medicine Personalized Genomics Genomic Medicine Precision Medicine Definition Application
Publikationsliste Claudia Götz
Publikationsliste Claudia Götz 1. Reinhard,B., Götz, C., and Faillard, H.: Synthesis of N-Acetyl-9-Oacetylneuraminic acid α-p-aminophenylthioketoside and its application as ligand in the affinity chromatography
BIOM 255 - Firestein, Winter 2009. Rheumatoid arthritis. Page 1
Rheumatoid arthritis Page 1 Vascular events in RA Synovium in rheumatoid arthritis Non-extra articular RA Extra articular RA Turesson, et al. Ann Rheum Dis. 2007;66:60 Normal Rheumatoid Arthritis Major
From DNA to Protein. Proteins. Chapter 13. Prokaryotes and Eukaryotes. The Path From Genes to Proteins. All proteins consist of polypeptide chains
Proteins From DNA to Protein Chapter 13 All proteins consist of polypeptide chains A linear sequence of amino acids Each chain corresponds to the nucleotide base sequence of a gene The Path From Genes
Launching a Cancer Genetic Laboratory to Enhance Diagnosis and Treatment
Launching a Cancer Genetic Laboratory to Enhance Diagnosis and Treatment Arthur L. Beaudet, M.D. Department of Molecular and Human Genetics Baylor College of Medicine ORIGIN AND PRECEDENT Decades of experience
2 nd PROCART Forum. October 9th, 2012
2 nd PROCART Forum October 9th, 2012 The main investments in cancer research 2012 research Spending 120 M Including INCa, Aviesan cancer, Ministry of Health cancer biology, cancer sciences, genomics Activities
Understanding the immune response to bacterial infections
Understanding the immune response to bacterial infections A Ph.D. (SCIENCE) DISSERTATION SUBMITTED TO JADAVPUR UNIVERSITY SUSHIL KUMAR PATHAK DEPARTMENT OF CHEMISTRY BOSE INSTITUTE 2008 CONTENTS Page SUMMARY
Bone cancer and normal cell lines
The Essentials of Life Science Research Globally Delivered Bone cancer and normal cell lines ATCC No. Name Tissue Cell Type Disease Oganism Age Ethnicity Genes Expressed CRL-1873 RS4;11 marrow lymphoblast
Module 2: Antibodies and Antigens
Module 2: Antibodies and Antigens Lecture 7: Antibodies and Antigens (part I) Antibodies may be defined as the proteins that recognize and neutralize any microbial toxin or foreign substance such as bacteria
Neoplasia gastrica cistica: GIST o leiomiosarcoma? Sebastiano Cacciaguerra U. O. Chirurgia Pediatrica Ospedale Garibaldi Catania
Neoplasia gastrica cistica: GIST o leiomiosarcoma? Sebastiano Cacciaguerra U. O. Chirurgia Pediatrica Ospedale Garibaldi Neoplasia gastrica cistica: GIST o leiomiosarcoma? Aims of presentation Atypical
Lecture 11 The Cell Cycle and Mitosis
Lecture 11 The Cell Cycle and Mitosis In this lecture Cell division Chromosomes The cell cycle Mitosis PPMAT Apoptosis What is cell division? Cells divide in order to reproduce themselves The cell cycle
Mechanisms of Hormonal Action Bryant Miles
Mechanisms of ormonal Action Bryant Miles Multicellular organisms need to coordinate metabolic activities. Complex signaling systems have evolved using chemicals called hormones to regulate cellular activities.
Complex multicellular organisms are produced by cells that switch genes on and off during development.
Home Control of Gene Expression Gene Regulation Is Necessary? By switching genes off when they are not needed, cells can prevent resources from being wasted. There should be natural selection favoring
High-Throughput Mutation Profiling Identifies Frequent Somatic Mutations in Advanced Gastric Adenocarcinoma
High-Throughput Mutation Profiling Identifies Frequent Somatic Mutations in Advanced Gastric Adenocarcinoma The Harvard community has made this article openly available. Please share how this access benefits
The challenge of selecting protein kinase assays for lead discovery optimization
Review The challenge of selecting protein kinase assays for lead discovery optimization 1. Introduction 2. Radiometric based assays 3. Fluorescence-based detection assays 4. Enzyme-linked immunosorbent
2013 W. H. Freeman and Company. 26 RNA Metabolism
2013 W. H. Freeman and Company 26 RNA Metabolism CHAPTER 26 RNA Metabolism Key topics: Transcription: DNA-dependent synthesis of RNA Capping and splicing: RNA processing Overview of RNA Function Ribonucleic
Stato dell arte e prospettive delle terapie a bersaglio molecolare nel carcinoma polmonare
Stato dell arte e prospettive delle terapie a bersaglio molecolare nel carcinoma polmonare Giorgio V. Scagliotti Università di Torino Dipartimento di scienze cliniche & biologiche giorgio.scagliotti@unito.it
H H N - C - C 2 R. Three possible forms (not counting R group) depending on ph
Amino acids - 0 common amino acids there are others found naturally but much less frequently - Common structure for amino acid - C, -N, and functional groups all attached to the alpha carbon N - C - C
Improving EGFR kinase inhibitor design for the targeted treatment of lung cancer.
Improving EGFR kinase inhibitor design for the targeted treatment of lung cancer. Shannon Tarby, Earl Benjamin III, and Ellis Benjamin Department of Chemistry, Richard Stockton College of New Jersey, 101
Fight or Flight Response: Play-by-Play
One of the most remarkable examples of cell communication is the fight or flight response. When a threat occurs, cells communicate rapidly to elicit physiological responses that help the body handle extraordinary
Turning off signal transducer and activator of transcription (STAT): The negative regulation of STAT signaling
Molecular mechanisms in allergy and clinical immunology Series editors: Wlliam T. Shearer, MD, PhD, Lanny J. Rosenwasser, MD, and Bruce S. Bochner, MD Turning off signal transducer and activator of transcription
Keywords: Lung Cancer, EGFR kinase, Inflammation
Improving EGFR kinase inhibitor design for the targeted treatment of lung cancer. Shannon Tarby, Earl Benjamin III, and Ellis Benjamin Department of Chemistry, Richard Stockton College of New Jersey, 101
Diabetes and Insulin Signaling
Diabetes and Insulin Signaling NATIONAL CENTER FOR CASE STUDY TEACHING IN SCIENCE by Kristy J. Wilson School of Mathematics and Sciences Marian University, Indianapolis, IN Part I Research Orientation
FGF-1 as Cosmetic Supplement
FGF-1 as Cosmetic Supplement Ing-Ming Chiu, Ph.D. Professor, Internal Medicine and Molecular and Cellular Biochemistry The Ohio State University Columbus, Ohio, U.S.A. GENTEON USA Fibroblast Growth Factor
Insulin resistance and hyperinsulinaemia in the development and progression of cancer
Clinical Science (2010) 118, 315 332 (Printed in Great Britain) doi:10.1042/cs20090399 315 R E V I E W Insulin resistance and hyperinsulinaemia in the development and progression of cancer Ian F. GODSLAND